Van Nevel Retires as NCI Communications Chief

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 9 No 2
Volume 9
Issue 2

BETHESDA, Md-J. Paul Van Nevel ended a 26-year career at the National Cancer Institute on Dec. 31, when he retired as associate director for cancer communications. He immediately began a new career as a communications consultant, with NCI as a client.

BETHESDA, Md—J. Paul Van Nevel ended a 26-year career at the National Cancer Institute on Dec. 31, when he retired as associate director for cancer communications. He immediately began a new career as a communications consultant, with NCI as a client.

NCI director Richard D. Klausner, MD, praised Mr. Van Nevel at the National Cancer Advisory Board meeting and thanked him for his contributions to the Institute. Dr. Klausner noted that Mr. Van Nevel would “help us negotiate the transition to the post-Paul Van Nevel era at NCI.”

Mr. Van Nevel joined NCI as deputy director of communications in 1973, following 5 years in media relations at Johns Hopkins. He was named head of NCI’s communications office in 1974. Nelvis Castro, chief of NCI’s health promotion branch, will serve as acting associate director for cancer communications.

Recent Videos
The addition of radioembolization to radiosensitizing chemotherapy may help concurrently treat patients with liver tumors and disease outside the liver.
In neuroendocrine tumor management, patients with insulinoma may be at risk of severe hypoglycemia following receipt of GLP-1 receptor agonists.
Decreasing the low-dose bath of proton therapy to the body may limit the impact of radiation on lymphocytes and affect tumor response.
4 experts are featured in this series.
4 experts are featured in this series.
According to Eyub Akdemir, MD, reducing EDIC may be feasible without compromising target coverage to reduce anticipated lymphopenia rates.
7 experts are featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.
Related Content